[HTML] mdpi.com

[HTML][HTML] Emerging evidence for the widespread role of glutamatergic dysfunction in neuropsychiatric diseases

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients, 2022 - mdpi.com
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …
被引用次数：34 相关文章
[HTML] nih.gov

[HTML][HTML] Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients, 2022 - ncbi.nlm.nih.gov
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases.

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients, 2022 - search.ebscohost.com
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients, 2022 - pubmed.ncbi.nlm.nih.gov
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …
[PDF] usp.br

[PDF][PDF] Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases

T McGrath, R Baskerville, MM Rogero, L Castell - Nutrients, 2022 - repositorio.usp.br
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …

[引用][C] Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients (Web), 2022 - jglobal.jst.go.jp
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in
Neuropsychiatric Diseases | Article Information | J-GLOBAL Art J-GLOBAL ID:202302282333991576 …

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients, 2022 - search.proquest.com
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases.

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients, 2022 - europepmc.org
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases

T McGrath, R Baskerville, M Rogero, L Castell - 2022 - agris.fao.org
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases.

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients, 2022 - europepmc.org
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …